Introduction

Overview of hepatitis E

Hepatitis E is a viral liver disease caused by the Hepatitis E virus (HEV), which primarily affects the liver, leading to inflammation and impairment of liver function. While the disease can be self-limiting and mild, it poses significant risks to vulnerable populations, such as pregnant women, for whom it can be life-threatening. HEV is predominantly transmitted through the fecal-oral route, particularly via contaminated water, making it a critical concern in regions with inadequate sanitation and poor access to clean water.

The global prevalence of Hepatitis E is concentrated in developing countries, particularly across parts of Asia, Africa, and the Middle East, where the environmental conditions and public health infrastructure allow for the rapid spread of the virus. In these regions, periodic outbreaks occur, often overwhelming local healthcare systems. Although HEV is less common in developed countries, sporadic cases have been reported, often linked to travel or zoonotic transmission from animals such as swine. The burden of the disease underscores the need for effective public health interventions aimed at controlling its spread.

Public health significance

Hepatitis E represents a growing concern for public health due to its high morbidity rates in endemic areas and its capacity to cause severe complications in pregnant women, where it can lead to maternal and fetal mortality. Infected individuals often exhibit flu-like symptoms, jaundice, and in severe cases, acute liver failure, which can be fatal without timely medical intervention. What makes Hepatitis E particularly concerning is its strong association with poor sanitation and hygiene practices, both of which are prevalent in many low-income countries.

The role of safe water access and sanitation cannot be overstated in the context of HEV transmission. Communities without reliable access to clean drinking water are especially vulnerable to outbreaks, as the virus can be easily transmitted via contaminated water sources. Additionally, poor personal hygiene practices and lack of adequate sewage disposal systems further exacerbate the risk of HEV spread.

HEV’s impact on healthcare systems, particularly in resource-limited settings, is substantial. During outbreaks, healthcare facilities often face surges in patients requiring care for acute liver failure or other complications, straining already limited resources. The healthcare burden extends beyond treatment, as preventive measures, public health campaigns, and vaccinations (where available) need to be implemented to reduce transmission rates. For these reasons, Hepatitis E is not just a health issue but a public health priority that requires coordinated policy responses to protect vulnerable populations and prevent future outbreaks.¹

Transmission and epidemiology of hepatitis E

Modes of transmission

Hepatitis E virus (HEV) is primarily transmitted through the fecal-oral route, making poor sanitation and contaminated water supplies the most common vectors for the spread of the disease. In many regions where water treatment infrastructure is lacking, HEV can quickly contaminate drinking water sources, leading to large-scale outbreaks. This is particularly prevalent in areas affected by seasonal flooding or during times of natural disaster, where sanitation systems are compromised.

In addition to waterborne transmission, zoonotic transmission is another recognized mode of HEV spread. Certain strains of HEV are harbored in animals, particularly swine, which can act as reservoirs for the virus. Human infection can occur through the consumption of undercooked or contaminated pork products, particularly in regions where food safety regulations may be inadequate. This zoonotic pathway is of increasing concern in some developed countries, where sporadic cases of HEV are linked to animal contact rather than poor sanitation.

Human-to-human transmission of HEV is relatively rare but can occur in specific circumstances, particularly during outbreaks in communities with close contact and poor hygiene practices. Healthcare-associated transmission is also possible in settings where infection control practices are insufficient. Though HEV is less likely to spread person-to-person compared to other types of hepatitis, isolated cases during outbreaks have been documented.

Geographic distribution

The distribution of Hepatitis E is uneven across the globe, with endemic regions primarily located in Southeast Asia, Sub-Saharan Africa, and parts of the Middle East. In these regions, environmental factors such as contaminated water supplies, poor sanitation, and inadequate infrastructure contribute to the continuous circulation of HEV. Seasonal outbreaks are often tied to weather patterns, such as monsoons or flooding, that exacerbate water contamination. The high prevalence of Hepatitis E in these areas results in a significant public health burden, particularly during large outbreaks.

Epidemic outbreaks of Hepatitis E are closely linked to waterborne transmission in low-income countries. Large-scale epidemics can overwhelm healthcare resources and lead to significant morbidity and mortality, especially in vulnerable populations. Epidemics are often sparked by the breakdown of public health infrastructure, such as during natural disasters, wars, or refugee crises, when access to clean water becomes severely limited.

Sporadic cases of Hepatitis E have also been reported in non-endemic, developed regions, highlighting the global mobility of the virus. In countries like Japan and some parts of Europe, zoonotic transmission through contaminated pork products has led to isolated cases. Furthermore, with increased international travel, individuals exposed to HEV in endemic areas may return to their home countries, bringing the virus with them. This demonstrates that while Hepatitis E is concentrated in specific regions, the risk of transmission exists worldwide, influenced by factors such as migration, trade, and food safety practices.

Vulnerable populations

While Hepatitis E can affect anyone exposed to the virus, certain populations are particularly vulnerable to severe outcomes. Pregnant women, especially those in the third trimester, are at a heightened risk. Hepatitis E infection in pregnant women often leads to a more severe form of the disease, with increased mortality rates and a higher likelihood of complications such as acute liver failure. This makes Hepatitis E a significant public health concern in regions where both pregnancy rates and HEV transmission are high.

Immunocompromised individuals, such as organ transplant recipients or people undergoing chemotherapy, are also at risk of  more severe and prolonged HEV infections. In these individuals, the virus may persist longer, leading to chronic infection and liver damage. Managing Hepatitis E in immunocompromised patients requires specialized care, often placing additional strain on healthcare systems in affected areas.

Refugee and displaced populations, particularly those living in overcrowded camps with inadequate sanitation, are at extreme risk of  Hepatitis E outbreaks. These populations often lack access to clean water and proper sewage disposal, creating ideal conditions for the fecal-oral transmission of the virus. Furthermore, their living conditions can exacerbate the spread of the virus, leading to swift outbreaks that are difficult to control. Addressing Hepatitis E in these vulnerable populations is crucial for preventing large-scale epidemics and ensuring public health safety in regions with ongoing humanitarian crises.²

Impact of hepatitis E on public health systems

Burden on healthcare systems

Hepatitis E outbreaks place a substantial burden on healthcare systems, particularly in endemic areas where infrastructure is already strained. During such outbreaks, hospitals experience a sharp increase in admissions, as patients suffering from symptoms such as jaundice, fever, and severe fatigue require medical care. This surge in demand can overwhelm medical facilities, particularly in rural or low-resource settings, where the capacity to handle large numbers of patients is often limited. The influx of patients can lead to shortages in beds, medical supplies, and healthcare personnel, exacerbating the situation.

Diagnostic challenges further compound the burden on healthcare systems. In many affected regions, healthcare facilities lack the necessary equipment and trained personnel to accurately diagnose Hepatitis E. Since the symptoms of Hepatitis E often overlap with other liver diseases, misdiagnosis is common, delaying proper treatment. Furthermore, diagnostic tests specific to HEV are not always readily available, especially in low-resource settings, where access to specialized laboratory services may be limited.

The need for specialized care during Hepatitis E outbreaks also adds to the strain on public health systems. Pregnant women, in particular, require intensive medical monitoring due to their increased risk of complications, including acute liver failure. Similarly, immunocompromised patients, such as those undergoing treatment for other illnesses or recovering from organ transplants, need more complex care, including antiviral therapies and constant monitoring for signs of chronic infection. Providing adequate care for these high-risk groups often stretches limited healthcare resources, highlighting the critical need for better preparedness and support in regions prone to Hepatitis E outbreaks.

Mortality and morbidity rates

One of the most alarming aspects of Hepatitis E is its high mortality rate among pregnant women, particularly those in the third trimester. In these cases, the virus can lead to fulminant hepatitis, a rapid and severe form of liver failure, which significantly increases the risk of maternal death. Mortality rates among pregnant women infected with Hepatitis E can reach as high as 25%, making it a significant contributor to maternal mortality in endemic areas. This loss has long-term effects on families and communities, leading to emotional distress and economic hardships.

The morbidity associated with Hepatitis E also presents a significant public health challenge. While many individuals recover from the virus without long-term consequences, some experience severe complications, including acute liver failure, which can result in prolonged hospital stays and a slow recovery. The long-term health effects of HEV infections, particularly in cases of chronic infection among immunocompromised individuals, are another concern. Chronic Hepatitis E can lead to progressive liver disease and cirrhosis, requiring ongoing medical treatment and monitoring.

The economic burden of lost productivity due to Hepatitis E infections also adds to the public health impact. In agriculture-dependent communities, which are often the hardest hit by outbreaks, those infected with the virus may be unable to work for weeks or months, leading to significant financial strain. This loss of labor affects not only the individuals and their families but also the broader community, as agriculture is often a key economic driver in these regions. The ripple effect of reduced workforce productivity can be felt throughout local economies, further deepening the economic toll of the disease.

Economic costs

The direct economic costs of Hepatitis E outbreaks are considerable. The healthcare system bears the brunt of these costs, with expenses related to patient treatment, hospitalization, and long-term care for severe cases. Hospital stays for patients with acute liver failure, in particular, can be prolonged and costly, requiring intensive medical interventions and monitoring. In areas where Hepatitis E is endemic, these recurring costs place a significant financial burden on already limited healthcare budgets, diverting resources away from other critical health services.

Indirect economic costs further exacerbate the strain on public health systems and local economies. Lost workforce productivity due to illness leads to reduced household incomes, particularly in regions where the majority of the population relies on physical labor, such as farming or construction. In the agricultural sector, where Hepatitis E outbreaks often coincide with key planting or harvesting seasons, the economic impact can be especially severe, leading to food shortages and increased poverty.

In low-income countries where other endemic diseases, such as malaria, tuberculosis, and HIV/AIDS, also demand significant resources, Hepatitis E presents a resource allocation dilemma. Governments and health agencies are often forced to prioritize between competing health threats, and funding for preventive measures like water, sanitation,  and Hepatitis E vaccination programs may be inadequate. The need to balance these competing health priorities makes it difficult to mount a comprehensive response to Hepatitis E, increasing the likelihood of future outbreaks and prolonged public health crises. Addressing these resource challenges requires a coordinated effort from both local governments and international health organizations to ensure that Hepatitis E receives the attention and resources necessary to mitigate its impact on public health systems.³

Public health policy responses to hepatitis E

Surveillance and monitoring

Effective surveillance and monitoring are crucial components of public health policies designed to control Hepatitis E. A robust disease surveillance system allows health authorities to detect outbreaks early, enabling timely interventions that can prevent widespread transmission. In regions where Hepatitis E is endemic, continuous monitoring helps identify patterns in transmission and allows public health agencies to allocate resources effectively during peak transmission seasons. Without proper surveillance, outbreaks can spread rapidly, overwhelming healthcare systems and increasing mortality rates.

However, setting up efficient surveillance systems in resource-limited settings presents significant challenges. Many of the countries most affected by Hepatitis E lack the financial and technological resources required to maintain consistent and accurate data collection. Limited healthcare infrastructure often means that cases of Hepatitis E go unreported, leading to an underestimation of the disease’s true burden. In remote areas, the lack of healthcare access further complicates data collection efforts, as affected individuals may never seek formal medical care.

International collaboration plays a key role in enhancing surveillance efforts, particularly in countries with limited capacity to manage outbreaks on their own. Organizations like the World Health Organization (WHO) assist in coordinating epidemiological monitoring across borders, ensuring that countries share critical data related to disease transmission. This collaboration facilitates the global tracking of Hepatitis E, particularly in terms of understanding how international travel, migration, and environmental changes influence the spread of the virus. Through such efforts, countries can strengthen their national surveillance systems and better prepare for potential outbreaks.

Vaccination strategies

Vaccination against Hepatitis E is an important public health tool, but its implementation faces significant hurdles. Currently, there is only one licensed Hepatitis E vaccine, available primarily in China, known as the HEV 239 vaccine. While clinical trials have shown the vaccine to be effective, its distribution remains limited due to regulatory and logistical challenges. Expanding access to this vaccine, particularly in highly endemic regions, could significantly reduce the incidence of Hepatitis E and save lives, especially among high-risk groups.

In developing vaccination policies for endemic regions, governments and health organizations must prioritize high-risk populations. Pregnant women, who face the highest risk of severe complications and death from Hepatitis E, are a key group for vaccination efforts. Healthcare workers are another priority, as they are frequently exposed to infectious patients during outbreaks. In regions where Hepatitis E is endemic, preemptive vaccination programs targeting these groups could dramatically reduce mortality rates and prevent the spread of the virus.

Despite its potential, vaccine implementation faces barriers that limit its widespread use. Funding is a major obstacle, as many of the countries where Hepatitis E is most prevalent lack the resources to purchase and distribute vaccines at scale. Supply chain issues, including the storage and transport of vaccines in areas with limited infrastructure, further complicate distribution efforts. Political will is also a factor; governments may prioritize other public health issues over Hepatitis E, especially in countries dealing with multiple endemic diseases. Overcoming these barriers will require sustained financial support from international donors, as well as coordinated policy efforts to make vaccination a key part of public health strategies in affected regions.

Water, sanitation, and hygiene (WASH) initiatives

One of the most effective ways to prevent the transmission of Hepatitis E is through improvements in water, sanitation, and hygiene (WASH) practices. Since Hepatitis E is primarily spread through the fecal-oral route via contaminated water, ensuring access to clean drinking water and proper sanitation facilities is crucial in controlling the virus. Public health policies that focus on WASH initiatives can significantly reduce the spread of Hepatitis E by addressing the root causes of transmission.

Public health campaigns aimed at improving sanitation and clean water access in affected areas are essential for long-term control of Hepatitis E. These campaigns often include educating communities about the importance of handwashing, the safe disposal of human waste, and boiling water before consumption in areas without access to treated water. In addition to raising awareness, these initiatives may also involve building or improving infrastructure, such as digging wells, installing water purification systems, and constructing latrines in communities where open defecation is common. 

Integrating WASH programs with broader infectious disease control measures is also critical for success. For example, Hepatitis E prevention can be combined with efforts to reduce the spread of diseases like cholera and typhoid, which are similarly linked to poor sanitation and contaminated water sources. By aligning WASH initiatives with overall public health strategies, governments can maximize the impact of their interventions, improving general health outcomes while reducing the specific burden of Hepatitis E. Additionally, these programs provide the foundation for resilience against future outbreaks, as improved sanitation and water infrastructure continue to benefit communities long after initial interventions have been completed.⁴

Challenges in policy implementation

Limited resources in affected areas

Financial constraints  

Developing countries often face significant budgetary limitations, which hinder their ability to allocate sufficient funds for Hepatitis E response efforts. The financial burden of healthcare systems strained by multiple endemic diseases can divert necessary resources away from Hepatitis E initiatives.

Competition for resources  

There is often fierce competition for limited health resources between Hepatitis E and other pressing public health priorities, such as malaria, HIV/AIDS, and tuberculosis. Policymakers may prioritize these more established health issues over Hepatitis E, leading to insufficient attention and funding for Hepatitis E prevention and treatment programs.

Infrastructure weaknesses

Poor water infrastructure  

In many regions, inadequate water supply and sanitation infrastructure exacerbate the transmission of Hepatitis E. Contaminated water sources can lead to outbreaks, particularly in densely populated urban areas and underserved rural communities. Lack of reliable access to clean water makes effective prevention strategies, such as proper hygiene practices, difficult to implement.

Lack of healthcare facilities  

Many affected regions lack healthcare facilities equipped to manage outbreaks of Hepatitis E. This includes shortages of trained healthcare personnel, laboratory facilities for testing, and adequate treatment options. The absence of robust healthcare infrastructure can delay the response to outbreaks and compromise patient care, further complicating efforts to control the disease.

Awareness and education gaps

Challenges in public health campaigns  

Raising awareness about Hepatitis E in rural communities poses significant challenges. Public health campaigns often struggle to effectively communicate the modes of transmission and preventive measures. Misinformation about the disease can spread rapidly in areas with limited access to reliable information sources, hindering efforts to educate the public.

Educational initiatives  

There is a pressing need for targeted educational initiatives that focus on promoting hygiene practices, vaccination (where applicable), and early recognition of symptoms. Educational programs must be culturally sensitive and tailored to local communities to ensure maximum impact.

Stigma and misinformation  

Stigmatization of those infected with Hepatitis E, often fueled by misinformation and lack of understanding, can deter individuals from seeking medical help or participating in public health initiatives. Lower literacy levels in some regions further complicate the dissemination of accurate health information, making it challenging to combat myths and encourage proactive health behaviors.

Addressing the challenges in policy implementation for Hepatitis E requires a multi-faceted approach that includes increasing funding, improving healthcare infrastructure, and enhancing community awareness and education. By tackling these issues, stakeholders can improve the effectiveness of Hepatitis E response efforts and ultimately reduce the burden of the disease in affected populations.⁵

International cooperation and policy development

Role of global health organizations

WHO’s guidance on hepatitis E prevention and control  

The World Health Organization (WHO) plays a crucial role in providing comprehensive guidelines and frameworks for Hepatitis E prevention and control. These guidelines include strategies for outbreak response, vaccination recommendations (where available), and approaches to enhance diagnostic capabilities. WHO’s efforts help establish standardized protocols that can be adopted by countries facing Hepatitis E outbreaks.

Contributions from non-governmental organizations (NGOs) and international aid agencies  

NGOs and international aid agencies contribute significantly to the fight against Hepatitis E by providing technical support, funding, and logistical assistance. These organizations often work on the ground to implement public health campaigns, improve water and sanitation infrastructure, and facilitate healthcare access in underserved regions. Their involvement is essential for tailored interventions that address local needs and conditions.

Cross-border initiatives

Regional vollaborations  

Hepatitis E is often a transboundary health issue, particularly in areas where water sources are shared among countries. Regional collaborations that focus on cross-border water management are vital for controlling the disease's spread. These initiatives can help establish joint monitoring systems for water quality and sanitation, thereby reducing the risk of outbreaks in border areas.

Sharing best practices  

Countries can benefit from sharing best practices related to surveillance, vaccination, and treatment protocols. Collaborative networks among neighboring countries can facilitate the exchange of knowledge, resources, and innovative approaches to managing Hepatitis E. This can include joint training programs for healthcare workers and synchronized public health campaigns to increase community awareness.

Funding and resource mobilization

Global funding mechanisms  

Global funding mechanisms, such as the Global Fund and the World Bank, play a pivotal role in supporting low-income countries in their efforts to manage Hepatitis E outbreaks. These mechanisms can provide critical resources for healthcare infrastructure improvements, outbreak response strategies, and research initiatives aimed at understanding the disease better. 

Importance of sustained financial investment  

Long-term financial investment is crucial for effective disease prevention and infrastructure development. One-time funding may help address immediate needs, but sustained investment is necessary to build resilient healthcare systems capable of managing Hepatitis E and other communicable diseases over time. Ensuring that countries have the financial support they need can lead to improved health outcomes and better preparedness for future outbreaks.

International cooperation and policy development are essential components in addressing the challenges posed by Hepatitis E. By leveraging the expertise and resources of global health organizations, fostering regional collaborations, and ensuring adequate funding, countries can implement effective strategies to combat Hepatitis E and protect public health. These efforts will contribute to a more coordinated global response, ultimately reducing the burden of the disease and improving health equity across affected regions.⁶

Summary

Hepatitis E significantly impacts public health policies in regions where the disease is endemic, shaping strategies to address its prevalence and effects on community health. The burden of Hepatitis E often prompts governments to reassess resource allocation within healthcare systems. As limited resources compete with other public health priorities, policies may prioritize improving sanitation, water quality, and healthcare infrastructure to prevent outbreaks. Moreover, Hepatitis E necessitates the integration of targeted prevention and response strategies into broader public health frameworks. This includes promoting vaccination (where applicable), improving disease surveillance, and enhancing healthcare worker training.

Public health policies increasingly focus on awareness campaigns aimed at educating communities about Hepatitis E transmission and prevention methods, addressing misinformation and stigma surrounding the disease to encourage health-seeking behaviors. Additionally, the presence of Hepatitis E influences the establishment of collaborations between governments, NGOs, and international health organizations, driving funding for infrastructure improvements and research initiatives aimed at better understanding and managing the disease. Finally, Hepatitis E shapes public health policies by influencing resource allocation, integrating disease management into health frameworks, promoting community awareness, and fostering collaborative efforts to enhance disease prevention and control.

FAQs

What is hepatitis E?  

Hepatitis E is a viral infection caused by the Hepatitis E virus (HEV), primarily transmitted through the fecal-oral route, often via contaminated water. It leads to inflammation of the liver, causing symptoms like fatigue, jaundice, nausea, and abdominal pain. While it can be acute and self-limiting, it may pose severe risks, especially for pregnant women and individuals with pre-existing liver conditions.

How is hepatitis E transmitted?  

Hepatitis E is primarily transmitted through consuming contaminated water or food. It is especially prevalent in areas with poor sanitation and inadequate water supply. Transmission can also occur through undercooked or raw pork and game meat, and in rare cases, it can be transmitted through blood transfusions or from mother to child during childbirth.

What are the symptoms of hepatitis E?

Common symptoms of Hepatitis E include fatigue, fever, nausea, abdominal pain, loss of appetite, and jaundice (yellowing of the skin and eyes). Symptoms typically appear 2 to 6 weeks after exposure to the virus. Many infected individuals may remain asymptomatic, especially in endemic regions.

How is hepatitis E diagnosed?  

Hepatitis E is diagnosed through blood tests that detect antibodies to the virus or the virus itself. These tests help differentiate between acute Hepatitis E infection and other forms of viral hepatitis. In some cases, healthcare providers may also assess liver function through liver enzyme tests.

Is there a vaccine for hepatitis E?  

Currently, there is a vaccine for Hepatitis E available in some countries, notably China, but it is not widely accessible globally. Preventive measures focus on improving sanitation, ensuring safe drinking water, and educating communities about proper hygiene practices to reduce transmission risk.

How can hepatitis E be prevented?

Preventing Hepatitis E involves ensuring access to clean water and proper sanitation, practicing good hygiene (such as regular handwashing), and avoiding consumption of undercooked or contaminated food. In areas where Hepatitis E is prevalent, public health campaigns to raise awareness about the disease and its transmission routes are crucial for prevention.